litlas
Log inCreate account

G. Webster Ross

Active 1992–2023

92
Papers
21,586
Citations
81
h-index
92
i10-index

Citations

Citations per year for G. Webster Ross1980: 1 citations1992: 1 citations1993: 6 citations1994: 1 citations1995: 2 citations1996: 11 citations1997: 17 citations1998: 19 citations1999: 32 citations2000: 67 citations2001: 70 citations2002: 131 citations2003: 168 citations2004: 165 citations2005: 180 citations2006: 206 citations2007: 273 citations2008: 257 citations2009: 301 citations2010: 307 citations2011: 325 citations2012: 312 citations2013: 306 citations2014: 295 citations2015: 231 citations2016: 264 citations2017: 262 citations2018: 205 citations2019: 678 citations2020: 709 citations2021: 652 citations2022: 583 citations2023: 378 citations2024: 493 citations2025: 244 citations2026: 2 citations1981–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,104 citing papers, 31.8% of this breakdownUnited Kingdom: 718 citing papers, 7.3% of this breakdownChina: 576 citing papers, 5.9% of this breakdownGermany: 471 citing papers, 4.8% of this breakdownItaly: 441 citing papers, 4.5% of this breakdownCanada: 406 citing papers, 4.1% of this breakdownAustralia: 293 citing papers, 3% of this breakdownNetherlands: 289 citing papers, 3% of this breakdownSpain: 271 citing papers, 2.8% of this breakdownFrance: 250 citing papers, 2.6% of this breakdownSweden: 248 citing papers, 2.5% of this breakdownJapan: 235 citing papers, 2.4% of this breakdown
0%31.8%Other 25.3%

Institutions

Fields

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Neuroscience9.3%
  • Health Professions1.6%
  • Agricultural and Biological Sciences1.4%
  • Nursing1.3%
  • Other4.9%

Topics

  • Parkinson's Disease Mechanisms and Treatments12.1%
  • Dementia and Cognitive Impairment Research5.9%
  • Alzheimer's disease research and treatments5.5%
  • Neurological disorders and treatments4.6%
  • Neurological Disease Mechanisms and Treatments2%
  • Nuclear Receptors and Signaling1.7%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Rotenone, Paraquat, and Parkinson’s Disease

    Authors: Caroline M. Tanner, Freya Kamel, G. Webster Ross, Jane A. Hoppin, Samuel M. Goldman, Monica Korell, Connie Marras, Grace S. Bhudhikanok, Meike Kasten, Anabel Chade, Kathleen Comyns, Marie Richards, Cheryl Meng, Benjamin Priestley, Hubert H. Fernandez, Franca Cambi, David M. Umbach, Aaron Blair, Dale P. Sandler, J. William Langston - Environmental Health Perspectives 2011 cited by 1,456

  2. Prevalence of Parkinson’s disease across North America

    Authors: Connie Marras, James C. Beck, James H. Bower, Eric Roberts, Beate Ritz, G. Webster Ross, Robert D. Abbott, Rodolfo Savica, Stephen K. Van Den Eeden, Allison W. Willis, CM Tanner - npj Parkinson s Disease 2018 cited by 1,014

  3. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Authors: José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl - Movement Disorders 2017 cited by 845

  4. Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

    Authors: G. Webster Ross - JAMA 2000 cited by 794

  5. Association of olfactory dysfunction with risk for future Parkinson's disease

    Authors: G. Webster Ross, Helen Petrovitch, Robert D. Abbott, Caroline M. Tanner, Jordan Popper, Kamal Masaki, Lenore J. Launer, Lon R. White - Annals of Neurology 2007 cited by 744

  6. Frequency of bowel movements and the future risk of Parkinson’s disease

    Authors: Robert D. Abbott, Helen Petrovitch, Lon R. White, Kamal Masaki, Caroline M. Tanner, J. David Curb, A. Grandinetti, Patricia Lanoie Blanchette, Jordan Popper, G. Webster Ross - Neurology 2001 cited by 827

  7. Excessive daytime sleepiness and subsequent development of Parkinson disease

    Authors: Robert D. Abbott, G. Webster Ross, Lon R. White, Caroline M. Tanner, Kamal Masaki, J. Stuart Nelson, J. David Curb, Helen Petrovitch - Neurology 2005 cited by 448

  8. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆

    Authors: Lenore J. Launer, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Dan Foley, Lon R. White, Richard J. Havlik - Neurobiology of Aging 2000 cited by 1,000

  9. Solvent exposures and parkinson disease risk in twins

    Authors: Samuel M. Goldman, Patricia Quinlan, G. Webster Ross, Connie Marras, Cheryl Meng, Grace S. Bhudhikanok, Kathleen Comyns, Monica Korell, Anabel Chade, Meike Kasten, Benjamin Priestley, Kelvin L. Chou, Hubert H. Fernandez, Franca Cambi, J. William Langston, Caroline M. Tanner - Annals of Neurology 2011 cited by 183

  10. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease

    Authors: Joshua Milber, Joseph V. Noorigian, James F. Morley, Helen Petrovitch, Lon R. White, G. Webster Ross, John E. Duda - Neurology 2012 cited by 161

  11. Concordance for Parkinson's disease in twins: A 20‐year update

    Authors: Samuel M. Goldman, Kenneth Marek, Ruth Ottman, Cheryl Meng, Kathleen Comyns, Piu Chan, Jinghong Ma, Connie Marras, J. William Langston, G. Webster Ross, Caroline M. Tanner - Annals of Neurology 2019 cited by 110

  12. Cerebral amyloid angiopathy and cognitive function

    Authors: Lisa A. Pfeifer, Lon R. White, G. Webster Ross, Helen Petrovitch, Lenore J. Launer - Neurology 2002 cited by 344

  13. Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies

    Authors: Lon R. White, Steven D. Edland, Laura S. Hemmy, Kathleen S. Montine, Chris Zarow, Joshua A. Sonnen, Jane Uyehara‐Lock, Rebecca P. Gelber, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Kelvin O. Lim, Lenore J. Launer, Thomas J. Montine - Neurology 2016 cited by 171

  14. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD

    Authors: G. Webster Ross, Helen Petrovitch, Robert D. Abbott, James R. Nelson, William R. Markesbery, Daron G. Davis, John Hardman, Lenore J. Launer, Kamal Masaki, Caroline M. Tanner, Lon R. White - Annals of Neurology 2004 cited by 271

  15. Occupation and risk of parkinsonism: a multicenter case-control study.

    Authors: Caroline M. Tanner, G. Webster Ross, Sarah A. Jewell, Robert A. Hauser, Joseph Jankovic, Stewart A. Factor, Susan Bressman, Amanda Deligtisch, Connie Marras, Kelly E. Lyons, Grace S. Bhudhikanok, Diana F. Roucoux, Cheryl Meng, Robert D. Abbott, J. William Langston - 2009 cited by 266

  16. Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease

    Authors: Karl Kieburtz, Barbara C. Tilley, Jordan J. Elm, Debra Babcock, Robert A. Hauser, G. Webster Ross, Alicia H. Augustine, Erika Augustine, Michael J. Aminoff, Iván Bódis-Wollner, James T. Boyd, Franca Cambi, Kelvin L. Chou, Chadwick W. Christine, Michelle Cines, Nabila Dahodwala, Lorelei Derwent, Richard B. Dewey, Katherine Hawthorne, David Houghton, Cornelia Kamp, Maureen A. Leehey, Mark Lew, Grace Liang, Sheng Luo, Zoltán Mari, John C. Morgan, Sotirios A. Parashos, Adriana Pérez, Helen Petrovitch, Suja S. Rajan, Sue Reichwein, Jessie Tatsuno Roth, Jay S. Schneider, Kathleen M. Shannon, David K. Simon, Tanya Simuni, Carlos Singer, Lewis Sudarsky, Caroline M. Tanner, Chizoba C. Umeh, Karen Williams, Anne‐Marie Wills - JAMA 2015 cited by 240

  17. Neuropathological changes in essential tremor: 33 cases compared with 21 controls

    Authors: Elan D. Louis, Phyllis L. Faust, J.-P. G. Vonsattel, Lawrence S. Honig, Ali H. Rajput, Chris Robinson, Ali H. Rajput, Rajesh Pahwa, Kelly E. Lyons, G. Webster Ross, Sarah Borden, Carol Moskowitz, A Lawton, Nora Hernández - Brain 2007 cited by 565

  18. Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men

    Authors: Sandra Kalmijn, Daniel J. Foley, Lon R. White, Cecil M. Burchfiel, J. David Curb, Helen Petrovitch, G. Webster Ross, Richard J. Havlik, Lenore J. Launer - Arteriosclerosis Thrombosis and Vascular Biology 2000 cited by 423

  19. Pooled Analysis of Tobacco Use and Risk of Parkinson Disease

    Authors: Beate Ritz, Alberto Ascherio, Harvey Checkoway, Karen Marder, Lorene M. Nelson, Walter A. Rocca, G. Webster Ross, Daniel Strickland, Stephen K. Van Den Eeden, Jay M. Gorell - Archives of Neurology 2007 cited by 365

  20. Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson’s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity

    Authors: Rodney C.P. Go, Michael J. Corley, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Alika K. Maunakea, Qimei He, Maarit Tiirikainen - BMC Neuroscience 2020 cited by 37

  21. Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram

    Authors: İbrahi̇m Karabayir, Fatma Gunturkun, Liam Butler, Samuel M. Goldman, Rishikesan Kamaleswaran, Robert L. Davis, Kalea Colletta, Lokesh Chinthala, John L. Jefferies, Kathleen L. Bobay, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Caroline M. Tanner, Oğuz Akbilgiç - Scientific Reports 2023 cited by 17

  22. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience

    Authors: G. Webster Ross, Robert D. Abbott, Helen Petrovitch, Caroline M. Tanner, Lon R. White - Parkinsonism & Related Disorders 2011 cited by 167

  23. Consumption of milk and calcium in midlife and the future risk of Parkinson disease

    Authors: M. Park, G. Webster Ross, Helen Petrovitch, Lon R. White, Kamal Masaki, J. Stuart Nelson, Caroline M. Tanner, J. David Curb, Patricia Lanoie Blanchette, Robert D. Abbott - Neurology 2005 cited by 146

  24. Changes in Selenoprotein P in Substantia Nigra and Putamen in Parkinson's Disease

    Authors: Frederick P. Bellinger, Arjun V. Raman, Rachel H. Rueli, Miyoko T. Bellinger, Andrea S.T. Dewing, Lucia A. Seale, Marilou A. Andres, Jane Uyehara‐Lock, Lon R. White, G. Webster Ross, Marla J. Berry - Journal of Parkinson s Disease 2012 cited by 76